UnitedHealth Group
Diversified healthcare company operating UnitedHealthcare insurance and Optum health services. Largest health insurer in the US with integrated care delivery, pharmacy benefits, and data analytics.
What the page says before deeper research
Quality, growth, value, ownership, risk, and source confidence.
Moat 88/100 with low retention risk.
Growth appears mixed from +9.7% YoY revenue growth.
Forward P/E of 19.3x versus +9.7% growth gives a 2.0x multiple-to-growth read.
No SEC-backed 13F layer is matched yet, so ownership confirmation is unavailable.
Retention and AI disruption risks are low; valuation is not flagged expensive.
Fundamentals from finnhub as of 2026-05-17; ownership confirmation is not available here.
Revenue growth is the cleanest top-line check in the current dataset.
Beginner valuation check
Data pending from FMP or Finnhub.
Positive price performance shows recent market sentiment, not a full investment thesis.
Forward P/E around 19.3x means investors pay about $19.3 for each expected $1 of future profit per share, usually the next 12 months or next fiscal year. It is a forecast, not a fact.
A P/E around 29.8x means investors pay about $29.8 for each $1 the company earned per share over the last 12 months, usually the last four quarterly reports.
Source: market data index. As of May 21, 2026. P/E can be unavailable or misleading when earnings are negative.
Beginner guide
UnitedHealth is like a helper that pays for when you go to the doctor, and also runs pharmacies and helps people get better when they're sick.
Diversified healthcare company operating UnitedHealthcare insurance and Optum health services. Largest health insurer in the US with integrated care delivery, pharmacy benefits, and data analytics.
UnitedHealth Group makes money through UnitedHealthcare (~55% of revenue) and Optum (~45% of revenue).
Dual engine moat: UnitedHealthcare's 50M+ member base creates massive network effects; employers and providers join because others are there
UnitedHealth Group can disappoint if execution, competition, valuation, or demand cycles weaken growth, margins, customer retention, or investor confidence.
UnitedHealth Group is like part of the healthcare toolkit: patients, providers, or researchers rely on it when quality and trust matter.
You are basically betting that UnitedHealth Group can keep turning unitedhealthcare into durable value while managing execution, competition, valuation, or demand cycles.
A 0-100 shortcut for how defensible the business looks in this company brief. UnitedHealth Group is scored at 88.
How painful it is for customers to leave. this company brief rates UnitedHealth Group as high.
Whether existing customers tend to spend more or less over time. The company brief model uses 105%.
The main pieces of the company here are UnitedHealthcare and Optum.
Price divided by earnings. It is a quick valuation check, but it can mislead when earnings are temporarily high, low, or negative.
A quarterly filing that shows what many large institutional investors owned at quarter end.
The first four questions
UNH’s combined UnitedHealthcare and Optum model can keep compounding if the company continues using its 50M+ member base, provider network, and cross-selling across insurance, pharmacy benefits, and care delivery.
UNH can lose momentum if execution slips in its insurance or Optum businesses, if customer retention weakens, or if the market decides the current valuation no longer matches growth and quality.
Forward P/E (19.3x)
Next earnings date unavailable from configured sources.
Bull / Neutral / Bear
UNH remains a large, integrated healthcare platform, and investors continue focusing on whether the business can convert that scale into steady growth at a reasonable forward multiple.
Forward P/E around 19.3x stays in line with the company’s growth and business quality.
UnitedHealthcare keeps benefiting from network effects and Optum keeps deepening the data-and-care flywheel, so the market stays confident in the integrated model.
Revenue growth remains positive near +9.7% or improves while the business mix stays anchored by UnitedHealthcare and Optum.
UNH remains a large, integrated healthcare platform, and investors continue focusing on whether the business can convert that scale into steady growth at a reasonable forward multiple.
Forward P/E around 19.3x stays in line with the company’s growth and business quality.
If execution weakens in insurance, pharmacy, or care delivery, the market may question whether the integrated model is still producing durable growth.
Demand, retention, or competitive pressure weakens while the valuation multiple fails to hold.
Beginner checklist
No configured earnings calendar source was provided.
Revenue growth is the cleanest top-line check in the current dataset.
No margin data was provided, so it should not be inferred from price action.
This is the current valuation anchor, but it should be read alongside growth and business quality.
No SEC-backed ownership rows are available for UNH yet.
No insider transaction data was provided.
For UNH, start with whether UnitedHealthcare is strengthening as the core operating engine.
UnitedHealth Group is exposure to unitedhealthcare with high switching costs and 105% net revenue retention.
Dual engine moat: UnitedHealthcare's 50M+ member base creates massive network effects; employers and providers join because others are there
The main question is whether the company can keep customer value compounding without margin pressure eroding the moat.
Use the simulator to walk through the workflows, systems, and data dependencies investors are effectively buying.
Business Lines
What's Inside
No SEC-backed 13F rows are matched for this ticker yet. We do not fabricate ownership rows.
- Dual engine moat: UnitedHealthcare's 50M+ member base creates massive network effects; employers and providers join because others are there
- Optum integration creates data flywheel: claims, pharmacy, and care delivery data feeds clinical and financial analytics competitors cannot replicate
- Regulatory moat: State-by-state insurance licensing, Medicare/Medicaid contracts, and provider network adequacy requirements create multi-year barriers to entry
- Provider network lock-in: Credentialing 1.3M+ providers takes years; switching insurers means providers must re-credential with new payer—massive friction
- 105% NRR reflects cross-sell from insurance to OptumRx, OptumCare, and OptumInsight; integrated offerings increase stickiness